190 related articles for article (PubMed ID: 35692191)
1. Compositional changes in fecal microbiota associated with clinical phenotypes and prognosis in Korean patients with inflammatory bowel disease.
Shin SY; Kim Y; Kim WS; Moon JM; Lee KM; Jung SA; Park H; Huh EY; Kim BC; Lee SC; Choi CH;
Intest Res; 2023 Jan; 21(1):148-160. PubMed ID: 35692191
[TBL] [Abstract][Full Text] [Related]
2. Fungal and Bacterial Loads: Noninvasive Inflammatory Bowel Disease Biomarkers for the Clinical Setting.
Sarrabayrouse G; Elias A; Yáñez F; Mayorga L; Varela E; Bartoli C; Casellas F; Borruel N; Herrera de Guise C; Machiels K; Vermeire S; Manichanh C
mSystems; 2021 Mar; 6(2):. PubMed ID: 33758031
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients.
Čipčić Paljetak H; Barešić A; Panek M; Perić M; Matijašić M; Lojkić I; Barišić A; Vranešić Bender D; Ljubas Kelečić D; Brinar M; Kalauz M; Miličević M; Grgić D; Turk N; Karas I; Čuković-Čavka S; Krznarić Ž; Verbanac D
Gut Microbes; 2022; 14(1):2083419. PubMed ID: 35695669
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of Crohn's disease and ulcerative colitis using the microbiome.
Kang DY; Park JL; Yeo MK; Kang SB; Kim JM; Kim JS; Kim SY
BMC Microbiol; 2023 Nov; 23(1):336. PubMed ID: 37951857
[TBL] [Abstract][Full Text] [Related]
5. Specificities of the fecal microbiota in inflammatory bowel disease.
Sokol H; Seksik P; Rigottier-Gois L; Lay C; Lepage P; Podglajen I; Marteau P; Doré J
Inflamm Bowel Dis; 2006 Feb; 12(2):106-11. PubMed ID: 16432374
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota signatures in inflammatory bowel disease.
Vestergaard MV; Allin KH; Eriksen C; Zakerska-Banaszak O; Arasaradnam RP; Alam MT; Kristiansen K; Brix S; Jess T
United European Gastroenterol J; 2024 Feb; 12(1):22-33. PubMed ID: 38041519
[TBL] [Abstract][Full Text] [Related]
7. Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.
Ma HQ; Yu TT; Zhao XJ; Zhang Y; Zhang HJ
World J Gastroenterol; 2018 Apr; 24(13):1464-1477. PubMed ID: 29632427
[TBL] [Abstract][Full Text] [Related]
8. Integrating the serum proteomic and fecal metaproteomic to analyze the impacts of overweight/obesity on IBD: a pilot investigation.
Yan P; Sun Y; Luo J; Liu X; Wu J; Miao Y
Clin Proteomics; 2023 Feb; 20(1):6. PubMed ID: 36759757
[TBL] [Abstract][Full Text] [Related]
9. Altered Fecal Microbiota in Paediatric Inflammatory Bowel Disease.
Maukonen J; Kolho KL; Paasela M; Honkanen J; Klemetti P; Vaarala O; Saarela M
J Crohns Colitis; 2015 Dec; 9(12):1088-95. PubMed ID: 26351391
[TBL] [Abstract][Full Text] [Related]
10. Microbial Disruptions in Inflammatory Bowel Disease: A Comparative Analysis.
Ma J; Wang K; Wang J; Zeng Q; Liu K; Zheng S; Chen Y; Yao J
Int J Gen Med; 2024; 17():1355-1367. PubMed ID: 38601196
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.
Knoll RL; Forslund K; Kultima JR; Meyer CU; Kullmer U; Sunagawa S; Bork P; Gehring S
Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G327-G339. PubMed ID: 28039159
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis.
Andoh A; Imaeda H; Aomatsu T; Inatomi O; Bamba S; Sasaki M; Saito Y; Tsujikawa T; Fujiyama Y
J Gastroenterol; 2011 Apr; 46(4):479-86. PubMed ID: 21253779
[TBL] [Abstract][Full Text] [Related]
13. Fecal microbiota profiles in treatment-naïve pediatric inflammatory bowel disease - associations with disease phenotype, treatment, and outcome.
Olbjørn C; Cvancarova Småstuen M; Thiis-Evensen E; Nakstad B; Vatn MH; Jahnsen J; Ricanek P; Vatn S; Moen AEF; Tannæs TM; Lindstrøm JC; Söderholm JD; Halfvarson J; Gomollón F; Casén C; Karlsson MK; Kalla R; Adams AT; Satsangi J; Perminow G
Clin Exp Gastroenterol; 2019; 12():37-49. PubMed ID: 30774408
[TBL] [Abstract][Full Text] [Related]
14. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
[TBL] [Abstract][Full Text] [Related]
15. Clostridium leptum group bacteria abundance and diversity in the fecal microbiota of patients with inflammatory bowel disease: a case-control study in India.
Kabeerdoss J; Sankaran V; Pugazhendhi S; Ramakrishna BS
BMC Gastroenterol; 2013 Jan; 13():20. PubMed ID: 23351032
[TBL] [Abstract][Full Text] [Related]
16. Intestinal Taxa Abundance and Diversity in Inflammatory Bowel Disease Patients: An Analysis including Covariates and Confounders.
Teofani A; Marafini I; Laudisi F; Pietrucci D; Salvatori S; Unida V; Biocca S; Monteleone G; Desideri A
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057440
[TBL] [Abstract][Full Text] [Related]
17. Effects of bowel cleansing on the composition of the gut microbiota in inflammatory bowel disease patients and healthy controls.
Bacsur P; Rutka M; Asbóth A; Resál T; Szántó K; Jójárt B; Bálint A; Ari E; Ajibola W; Kintses B; Fehér T; Pigniczki D; Bor R; Fábián A; Maléth J; Szepes Z; Farkas K; Molnár T
Therap Adv Gastroenterol; 2023; 16():17562848231174298. PubMed ID: 37324319
[TBL] [Abstract][Full Text] [Related]
18. A Machine Learning-Based Diagnostic Model for Crohn's Disease and Ulcerative Colitis Utilizing Fecal Microbiome Analysis.
Kim H; Na JE; Kim S; Kim TO; Park SK; Lee CW; Kim KO; Seo GS; Kim MS; Cha JM; Koo JS; Park DI
Microorganisms; 2023 Dec; 12(1):. PubMed ID: 38257863
[TBL] [Abstract][Full Text] [Related]
19. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease.
Nishino K; Nishida A; Inoue R; Kawada Y; Ohno M; Sakai S; Inatomi O; Bamba S; Sugimoto M; Kawahara M; Naito Y; Andoh A
J Gastroenterol; 2018 Jan; 53(1):95-106. PubMed ID: 28852861
[TBL] [Abstract][Full Text] [Related]
20. Metagenomic and bile acid metabolomic analysis of fecal microbiota transplantation for recurrent Clostridiodes difficile and/or inflammatory bowel diseases.
Ramos RJ; Zhu C; Joseph DF; Thaker S; Lacomb JF; Markarian K; Lee HJ; Petrov JC; Monzur F; Buscaglia JM; Chawla A; Small-Harary L; Gathungu G; Morganstern JA; Yang J; Li J; Pamer EG; Robertson CE; Frank DN; Cross JR; Li E
Med Res Arch; 2022 Oct; 10(10):. PubMed ID: 36618438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
